Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.38 - $6.48 $30,835 - $45,619
-7,040 Reduced 21.36%
25,917 $129,000
Q1 2024

May 14, 2024

BUY
$3.54 - $6.84 $116,667 - $225,425
32,957 New
32,957 $203,000
Q3 2023

Nov 14, 2023

BUY
$3.56 - $5.75 $69,978 - $113,027
19,657 New
19,657 $113,000
Q1 2023

May 15, 2023

BUY
$3.58 - $6.3 $196,330 - $345,498
54,841 New
54,841 $237,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.